Targeted-release budesonide versus systemic corticosteroids in IgA nephropathy: a real-world comparative study
BackgroundTargeted-release budesonide (Nefecon) has demonstrated efficacy in randomized trials for IgA nephropathy (IgAN), yet direct comparative real-world evidence against systemic corticosteroids is scarce, limiting clinical decision-making.MethodsW…